Market Research Logo

Apotex Inc - Strategic SWOT Analysis Review

Apotex Inc - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • HighlightsApotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. The company also offers biosimilars, active pharmaceutical ingredients and pharmaceuticals. It carries out the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and development (R&D) facilities in Montreal, Richmond Hill, Brantford, Windsor, Winnipeg, Toronto, Etobicoke, Mississauga, London, Calgary and Vancouver. It serves patients, healthcare providers and payers, governments and other pharmaceutical manufacturers. It operates through subsidiaries, joint ventures and licensing agreements across Americas, Europe, the Middle East, Africa and Asia-Pacific. Apotex is headquartered in Toronto, Ontario, Canada.

    Apotex Inc Key Recent Developments

    Dec 19,2018: Apotex names Jeff Watson as leader after CEO Jack Kay departs
    Aug 10,2018: FDA approves first generic drug under new CGT designation
    Aug 08,2018: CannTrust and Apotex accelerate partnership to fuel global expansion in medical cannabis market
    May 09,2018: Apotex Announces Proposed Merger of AUS & NZ Operations
    Mar 08,2018: Advisory - Chipped pills in additional packages of Alysena 21 and 28 birth control pills

    Reasons to Buy
    • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
    • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
    • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
    • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
    Note: Some sections may be missing if data is unavailable for the company.


    Section 1 - About the Company
    Apotex Inc - Key Facts
    Apotex Inc - Key Employees
    Apotex Inc - Key Employee Biographies
    Apotex Inc - Major Products and Services
    Apotex Inc - History
    Apotex Inc - Company Statement
    Apotex Inc - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Section 2 - Company Analysis
    Company Overview
    Apotex Inc - Business Description
    Apotex Inc - SWOT Analysis
    SWOT Analysis - Overview
    Apotex Inc - Strengths
    Apotex Inc - Weaknesses
    Apotex Inc - Opportunities
    Apotex Inc - Threats
    Apotex Inc - Key Competitors
    Section 3 - Company’s Lifesciences Financial Deals and Alliances
    Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
    Apotex Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
    Apotex Inc, Recent Deals Summary
    Section 4 - Company’s Recent Developments
    Aug 10, 2018: FDA approves first generic drug under new CGT designation
    Aug 08, 2018: CannTrust and Apotex accelerate partnership to fuel global expansion in medical cannabis market
    May 09, 2018: Apotex Announces Proposed Merger of AUS & NZ Operations
    Mar 08, 2018: Advisory - Chipped pills in additional packages of Alysena 21 and 28 birth control pills
    Section 5 - Appendix
    Methodology
    About GlobalData
    Contact Us
    Disclaimer
    List of Tables
    Apotex Inc, Key Facts
    Apotex Inc, Key Employees
    Apotex Inc, Key Employee Biographies
    Apotex Inc, Major Products and Services
    Apotex Inc, History
    Apotex Inc, Subsidiaries
    Apotex Inc, Key Competitors
    Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
    Apotex Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
    Apotex Inc, Recent Deals Summary
    List of Figures
    Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
    Apotex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Share this report